Competing Risks, Treatment Switching, and Informative Censoring

Laine Elliott Thomas^{1

2

3}, Mintu P Turakhia^{4

5

6}, Michael J Pencina^{1

2

7}

Affiliations

¹ Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
² Duke Clinical Research Institute, Durham, North Carolina.
³ Assistant Editor for Statistics, JAMA Cardiology.
⁴ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
⁵ Center for Digital Health, Stanford University School of Medicine, Stanford, California.
⁶ Associate Editor, JAMA Cardiology .
⁷ Deputy Editor for Statistics, JAMA Cardiology.

Comment

Laine Elliott Thomas et al. JAMA Cardiol. 2021.

. 2021 Aug 1;6(8):871-873.

doi: 10.1001/jamacardio.2021.1239.

Laine Elliott Thomas^{1

2

3}, Mintu P Turakhia^{4

5

6}, Michael J Pencina^{1

2

7}

¹ Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
² Duke Clinical Research Institute, Durham, North Carolina.
³ Assistant Editor for Statistics, JAMA Cardiology.
⁴ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
⁵ Center for Digital Health, Stanford University School of Medicine, Stanford, California.
⁶ Associate Editor, JAMA Cardiology .
⁷ Deputy Editor for Statistics, JAMA Cardiology.

No abstract available

Comment on

Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors.
Abdel-Qadir H, Singh SM, Pang A, Austin PC, Jackevicius CA, Tu K, Dorian P, Ko DT. Abdel-Qadir H, et al. JAMA Cardiol. 2021 Aug 1;6(8):918-925. doi: 10.1001/jamacardio.2021.1232. JAMA Cardiol. 2021. PMID: 34009232 Free PMC article.